| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
529,039 |
475,605 |
$39.69M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
88,578 |
86,354 |
$13.98M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
33,100 |
28,967 |
$12.85M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
4,255 |
4,093 |
$12.78M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
23,741 |
22,304 |
$6.12M |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
3,775 |
3,512 |
$4.35M |
| J0475 |
Injection, baclofen, 10 mg |
5,178 |
3,641 |
$3.75M |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
23,678 |
22,967 |
$1.76M |
| G0378 |
Hospital observation service, per hour |
3,500 |
3,008 |
$1.61M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
2,108 |
2,003 |
$1.59M |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
5,196 |
4,800 |
$1.55M |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
3,272 |
3,114 |
$1.49M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,780 |
3,165 |
$1.38M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
2,493 |
2,445 |
$1.26M |
| 95782 |
|
1,666 |
1,521 |
$1.23M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,003 |
1,705 |
$1.16M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
8,588 |
8,466 |
$1.13M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
1,306 |
1,259 |
$1.13M |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
40,242 |
38,361 |
$976K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
120,220 |
99,336 |
$822K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
1,082 |
653 |
$816K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
696 |
583 |
$695K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
4,068 |
2,391 |
$690K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
8,453 |
3,744 |
$674K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
5,697 |
5,637 |
$614K |
| 80053 |
Comprehensive metabolic panel |
60,687 |
45,251 |
$612K |
| A0425 |
Ground mileage, per statute mile |
4,799 |
3,896 |
$611K |
| 41010 |
|
471 |
451 |
$529K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,758 |
5,648 |
$495K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
26,562 |
24,201 |
$474K |
| J2323 |
Injection, natalizumab, 1 mg |
144 |
97 |
$471K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
24,768 |
22,075 |
$470K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
26,537 |
24,185 |
$468K |
| 90677 |
|
4,972 |
4,819 |
$463K |
| 93325 |
|
11,784 |
10,762 |
$458K |
| 92587 |
|
3,057 |
2,929 |
$438K |
| 94010 |
|
7,740 |
7,022 |
$420K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
7,013 |
6,596 |
$357K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
39,326 |
36,161 |
$353K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
22,307 |
21,047 |
$349K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
42,664 |
30,882 |
$346K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
7,778 |
7,258 |
$337K |
| 84443 |
Thyroid stimulating hormone (TSH) |
25,707 |
23,924 |
$332K |
| 54161 |
|
362 |
354 |
$322K |
| 90670 |
|
5,322 |
4,898 |
$318K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,030 |
1,583 |
$306K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,426 |
2,403 |
$305K |
| 36415 |
Collection of venous blood by venipuncture |
85,378 |
64,280 |
$302K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,450 |
2,827 |
$292K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
27,275 |
23,911 |
$292K |
| 92579 |
|
5,911 |
5,675 |
$273K |
| 93320 |
|
5,164 |
4,836 |
$262K |
| 71046 |
Radiologic examination, chest; 2 views |
6,472 |
5,134 |
$261K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,820 |
3,297 |
$257K |
| 70450 |
Computed tomography, head or brain; without contrast material |
783 |
680 |
$248K |
| 92567 |
|
18,232 |
17,609 |
$247K |
| J2704 |
Injection, propofol, 10 mg |
23,104 |
19,415 |
$240K |
| 74018 |
|
5,880 |
5,386 |
$240K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
3,508 |
2,555 |
$237K |
| 86900 |
|
10,766 |
9,099 |
$230K |
| 95816 |
|
1,651 |
1,576 |
$228K |
| J3490 |
Unclassified drugs |
17,970 |
10,848 |
$227K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,875 |
4,679 |
$209K |
| 80061 |
Lipid panel |
14,236 |
12,778 |
$205K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
5,967 |
5,276 |
$196K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
24,763 |
22,599 |
$195K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,591 |
2,452 |
$193K |
| 76770 |
|
2,048 |
1,894 |
$189K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
27,087 |
22,227 |
$178K |
| 83655 |
|
13,447 |
12,817 |
$174K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,216 |
2,028 |
$172K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
30,045 |
28,003 |
$169K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
1,806 |
1,671 |
$165K |
| 92551 |
|
12,341 |
11,795 |
$158K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
10,286 |
9,131 |
$143K |
| 84439 |
|
16,117 |
15,286 |
$138K |
| 87536 |
|
3,154 |
2,639 |
$132K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
11,184 |
8,191 |
$129K |
| 86780 |
|
12,761 |
11,553 |
$128K |
| 81416 |
|
13 |
12 |
$126K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
1,392 |
1,311 |
$124K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,599 |
3,723 |
$122K |
| 95117 |
|
4,345 |
2,354 |
$121K |
| 59025 |
Fetal non-stress test |
1,696 |
1,302 |
$117K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
19,205 |
18,233 |
$116K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
18,692 |
16,295 |
$113K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,444 |
1,315 |
$109K |
| 96161 |
|
10,483 |
9,495 |
$107K |
| 96127 |
|
14,574 |
13,857 |
$101K |
| 42830 |
|
56 |
53 |
$99K |
| 86850 |
|
10,438 |
8,853 |
$95K |
| 82728 |
|
8,877 |
7,553 |
$95K |
| 72082 |
|
3,554 |
3,474 |
$95K |
| 81025 |
|
15,640 |
12,122 |
$94K |
| 80305 |
|
10,812 |
7,793 |
$91K |
| 85027 |
|
24,769 |
22,094 |
$88K |
| 83516 |
|
3,233 |
2,606 |
$86K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
5,716 |
5,206 |
$82K |
| 93296 |
|
7,166 |
6,257 |
$80K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,014 |
877 |
$78K |
| 83735 |
|
12,567 |
9,217 |
$78K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
13 |
12 |
$77K |
| 83880 |
|
2,630 |
2,004 |
$77K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,209 |
1,081 |
$77K |
| 76775 |
|
1,898 |
1,847 |
$76K |
| 90837 |
Psychotherapy, 53 minutes with patient |
2,372 |
1,360 |
$76K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,942 |
2,193 |
$76K |
| 62370 |
|
1,387 |
1,123 |
$75K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,481 |
2,752 |
$75K |
| 87081 |
|
11,469 |
11,260 |
$72K |
| 90686 |
|
14,501 |
13,529 |
$72K |
| 82570 |
|
7,998 |
7,017 |
$72K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
153 |
129 |
$71K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
1,104 |
817 |
$70K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
19,031 |
16,843 |
$68K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,855 |
2,025 |
$68K |
| 86360 |
|
3,072 |
2,421 |
$68K |
| 86140 |
|
14,019 |
12,706 |
$66K |
| 49452 |
|
94 |
89 |
$64K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,347 |
2,044 |
$64K |
| 87631 |
|
876 |
871 |
$63K |
| 80076 |
|
9,884 |
8,283 |
$63K |
| 90834 |
Psychotherapy, 45 minutes with patient |
2,154 |
1,504 |
$63K |
| 72170 |
|
1,558 |
1,476 |
$62K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
151 |
129 |
$62K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,187 |
1,565 |
$61K |
| G0008 |
Administration of influenza virus vaccine |
4,953 |
4,443 |
$59K |
| 86359 |
|
3,203 |
2,580 |
$59K |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
76 |
73 |
$59K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,343 |
7,924 |
$59K |
| 82784 |
|
7,969 |
7,390 |
$58K |
| 95715 |
|
151 |
97 |
$55K |
| 87653 |
|
2,768 |
2,618 |
$54K |
| 80197 |
|
11,277 |
8,193 |
$54K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
1,371 |
1,192 |
$53K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
220 |
214 |
$51K |
| 86901 |
|
10,673 |
9,087 |
$49K |
| 72141 |
|
137 |
136 |
$48K |
| 36591 |
|
1,797 |
1,100 |
$47K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
898 |
442 |
$46K |
| 83970 |
|
2,088 |
1,656 |
$46K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
11,258 |
10,584 |
$46K |
| 92582 |
|
700 |
678 |
$45K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,209 |
9,051 |
$43K |
| 85651 |
|
14,488 |
13,324 |
$43K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,274 |
3,182 |
$43K |
| C1769 |
Guide wire |
1,213 |
942 |
$40K |
| 81002 |
|
12,517 |
11,619 |
$39K |
| 90791 |
Psychiatric diagnostic evaluation |
420 |
412 |
$39K |
| 82977 |
|
8,724 |
7,479 |
$39K |
| 81415 |
|
15 |
13 |
$38K |
| 76830 |
Ultrasound, transvaginal |
554 |
497 |
$38K |
| J7999 |
Compounded drug, not otherwise classified |
2,340 |
1,714 |
$37K |
| 87799 |
|
1,203 |
942 |
$37K |
| 97803 |
|
998 |
951 |
$36K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
759 |
673 |
$36K |
| 90715 |
|
1,275 |
1,170 |
$36K |
| 85610 |
|
6,813 |
5,942 |
$34K |
| 0001A |
|
1,036 |
959 |
$33K |
| 76825 |
|
148 |
136 |
$33K |
| 86803 |
|
6,286 |
5,806 |
$33K |
| 85018 |
|
15,302 |
14,561 |
$33K |
| 0002A |
|
957 |
903 |
$33K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
108 |
87 |
$33K |
| 90656 |
|
3,018 |
2,946 |
$33K |
| 14040 |
|
85 |
84 |
$33K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
70 |
40 |
$31K |
| 95819 |
|
227 |
220 |
$30K |
| 85045 |
|
11,727 |
10,004 |
$30K |
| 71045 |
Radiologic examination, chest; single view |
415 |
348 |
$30K |
| 84100 |
|
10,629 |
8,154 |
$30K |
| 81001 |
|
16,943 |
15,209 |
$30K |
| 96415 |
|
298 |
239 |
$30K |
| 86364 |
|
2,712 |
2,639 |
$29K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
268 |
245 |
$28K |
| 0071A |
|
700 |
698 |
$28K |
| 82248 |
|
3,987 |
3,041 |
$28K |
| 82950 |
|
3,423 |
3,227 |
$27K |
| 96900 |
|
1,151 |
210 |
$27K |
| 86832 |
|
323 |
260 |
$26K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
1,285 |
1,222 |
$26K |
| 87340 |
|
9,823 |
8,814 |
$26K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
1,506 |
1,423 |
$26K |
| 95700 |
|
179 |
155 |
$26K |
| 95991 |
|
516 |
387 |
$25K |
| 76820 |
|
1,239 |
886 |
$24K |
| 92556 |
|
535 |
516 |
$24K |
| 0072A |
|
586 |
586 |
$24K |
| 86833 |
|
289 |
232 |
$23K |
| 92060 |
|
3,975 |
3,836 |
$23K |
| 92552 |
|
814 |
790 |
$23K |
| 82962 |
|
2,093 |
1,102 |
$22K |
| 83550 |
|
2,926 |
2,669 |
$22K |
| 72146 |
|
107 |
107 |
$21K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
627 |
232 |
$21K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
39 |
37 |
$20K |
| 90620 |
|
546 |
486 |
$19K |
| 86258 |
|
1,956 |
1,904 |
$19K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
173 |
103 |
$19K |
| 36416 |
|
11,862 |
11,203 |
$19K |
| 90480 |
|
756 |
738 |
$18K |
| 83690 |
|
2,094 |
1,858 |
$18K |
| 92555 |
|
1,224 |
1,184 |
$18K |
| 83021 |
|
2,743 |
1,980 |
$18K |
| 83540 |
|
3,330 |
3,004 |
$18K |
| 84702 |
|
1,388 |
1,169 |
$17K |
| 99173 |
|
12,013 |
11,564 |
$17K |
| 83605 |
|
1,136 |
769 |
$17K |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
198 |
163 |
$17K |
| 93304 |
|
75 |
75 |
$16K |
| 84156 |
|
5,602 |
4,854 |
$16K |
| 85730 |
|
1,982 |
1,742 |
$16K |
| 82565 |
|
2,155 |
1,893 |
$16K |
| 92611 |
|
240 |
234 |
$15K |
| 87070 |
|
1,404 |
1,209 |
$15K |
| 73590 |
|
256 |
223 |
$15K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
106 |
94 |
$14K |
| 82261 |
|
14 |
13 |
$14K |
| 97802 |
|
268 |
258 |
$14K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
39 |
32 |
$14K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,260 |
1,906 |
$14K |
| 74230 |
|
223 |
216 |
$13K |
| 73552 |
|
262 |
236 |
$13K |
| 47000 |
|
13 |
13 |
$13K |
| 93308 |
|
140 |
106 |
$13K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
422 |
402 |
$12K |
| 93975 |
|
67 |
67 |
$12K |
| 76981 |
|
196 |
194 |
$12K |
| 36430 |
|
83 |
61 |
$11K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
814 |
678 |
$11K |
| 95076 |
|
37 |
26 |
$11K |
| 81229 |
|
43 |
37 |
$11K |
| 96376 |
|
324 |
159 |
$10K |
| 86003 |
|
249 |
237 |
$10K |
| 72081 |
|
746 |
719 |
$10K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
168 |
153 |
$9K |
| 54360 |
|
12 |
12 |
$9K |
| 93321 |
|
327 |
278 |
$9K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
374 |
339 |
$9K |
| 73560 |
|
440 |
432 |
$9K |
| 90461 |
|
877 |
854 |
$8K |
| 93226 |
|
116 |
110 |
$8K |
| 82803 |
|
417 |
304 |
$8K |
| 77072 |
|
545 |
514 |
$8K |
| 73610 |
|
138 |
127 |
$8K |
| 88342 |
|
104 |
100 |
$8K |
| 82610 |
|
1,555 |
1,398 |
$8K |
| 70480 |
|
54 |
52 |
$8K |
| 86762 |
|
5,174 |
4,512 |
$8K |
| 82550 |
|
898 |
810 |
$8K |
| 87497 |
|
448 |
356 |
$7K |
| 87077 |
|
922 |
789 |
$7K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
288 |
220 |
$7K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
388 |
339 |
$7K |
| 43762 |
|
37 |
36 |
$7K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
204 |
191 |
$7K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
240 |
186 |
$6K |
| 93270 |
|
173 |
171 |
$6K |
| 86255 |
|
510 |
447 |
$6K |
| 84460 |
|
1,225 |
1,128 |
$6K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
79 |
70 |
$6K |
| 82139 |
|
983 |
801 |
$6K |
| 97161 |
|
79 |
72 |
$6K |
| 84484 |
|
544 |
393 |
$5K |
| 97162 |
|
72 |
62 |
$5K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
260 |
200 |
$5K |
| 31622 |
|
26 |
24 |
$5K |
| 84450 |
|
1,159 |
1,066 |
$5K |
| 88720 |
|
1,415 |
1,297 |
$5K |
| 96910 |
|
527 |
99 |
$5K |
| 90723 |
|
7,124 |
6,674 |
$5K |
| 84144 |
|
593 |
528 |
$5K |
| 86038 |
|
1,155 |
1,053 |
$5K |
| 82105 |
|
1,206 |
1,097 |
$5K |
| 82607 |
|
464 |
379 |
$5K |
| 73090 |
|
234 |
197 |
$5K |
| 86706 |
|
990 |
905 |
$4K |
| 96112 |
|
45 |
43 |
$4K |
| 83520 |
|
280 |
246 |
$4K |
| C1889 |
Implantable/insertable device, not otherwise classified |
2,067 |
1,936 |
$4K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
15 |
14 |
$4K |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
56 |
41 |
$4K |
| 90661 |
|
641 |
634 |
$4K |
| 90380 |
|
121 |
103 |
$4K |
| 92553 |
|
21 |
17 |
$4K |
| 87186 |
|
425 |
378 |
$4K |
| 87481 |
|
142 |
137 |
$4K |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
799 |
778 |
$4K |
| 90688 |
|
373 |
332 |
$3K |
| 93356 |
|
163 |
144 |
$3K |
| 84520 |
|
712 |
664 |
$3K |
| 82042 |
|
732 |
677 |
$3K |
| J1644 |
Injection, heparin sodium, per 1000 units |
711 |
361 |
$3K |
| 83615 |
|
841 |
705 |
$3K |
| 86704 |
|
868 |
805 |
$3K |
| 96160 |
|
378 |
334 |
$3K |
| 52287 |
|
14 |
12 |
$3K |
| 76827 |
|
148 |
136 |
$3K |
| 81407 |
|
30 |
24 |
$3K |
| 74019 |
|
62 |
55 |
$3K |
| 90832 |
Psychotherapy, 30 minutes with patient |
61 |
53 |
$3K |
| 96380 |
|
121 |
112 |
$3K |
| 92557 |
|
54 |
51 |
$3K |
| 80195 |
|
256 |
220 |
$3K |
| 73070 |
|
85 |
80 |
$3K |
| 86902 |
|
50 |
39 |
$3K |
| 92083 |
|
482 |
442 |
$3K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
72 |
38 |
$2K |
| 0124A |
|
71 |
67 |
$2K |
| G0009 |
Administration of pneumococcal vaccine |
135 |
125 |
$2K |
| 76813 |
|
79 |
68 |
$2K |
| 84403 |
|
110 |
102 |
$2K |
| 81408 |
|
15 |
12 |
$2K |
| 99195 |
|
51 |
48 |
$2K |
| 73630 |
|
138 |
128 |
$2K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
63 |
60 |
$2K |
| 77073 |
|
62 |
60 |
$2K |
| 82043 |
|
164 |
146 |
$2K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
132 |
111 |
$2K |
| 82330 |
|
273 |
227 |
$2K |
| 73100 |
|
145 |
130 |
$2K |
| 82040 |
|
1,004 |
927 |
$2K |
| 90685 |
|
164 |
158 |
$2K |
| Q3014 |
Telehealth originating site facility fee |
749 |
690 |
$2K |
| J1171 |
Injection, hydromorphone, 0.1 mg |
273 |
221 |
$2K |
| 90648 |
|
10,124 |
9,556 |
$2K |
| 86376 |
|
414 |
385 |
$2K |
| 76857 |
|
24 |
24 |
$2K |
| 82104 |
|
387 |
365 |
$2K |
| 83993 |
|
111 |
109 |
$2K |
| 90678 |
|
18 |
15 |
$2K |
| 84305 |
|
98 |
92 |
$2K |
| 82390 |
|
576 |
523 |
$2K |
| 90716 |
|
2,543 |
2,443 |
$2K |
| 87205 |
|
290 |
252 |
$2K |
| 88313 |
|
41 |
37 |
$2K |
| 86481 |
|
24 |
24 |
$2K |
| 92133 |
|
288 |
259 |
$2K |
| 96138 |
|
64 |
63 |
$2K |
| 76885 |
|
32 |
29 |
$2K |
| 96450 |
|
16 |
12 |
$2K |
| 0081A |
|
40 |
39 |
$1K |
| 81513 |
|
13 |
13 |
$1K |
| 96136 |
|
151 |
150 |
$1K |
| 96111 |
|
14 |
14 |
$1K |
| 96113 |
|
17 |
16 |
$1K |
| 94729 |
|
72 |
62 |
$1K |
| 87522 |
Neg quan hep c or qual rna |
266 |
239 |
$1K |
| 64615 |
|
15 |
12 |
$1K |
| 87102 |
|
42 |
37 |
$1K |
| 77080 |
|
34 |
27 |
$1K |
| 97763 |
|
15 |
12 |
$1K |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
407 |
366 |
$1K |
| 92526 |
|
15 |
12 |
$1K |
| 93017 |
|
15 |
14 |
$1K |
| 62369 |
|
27 |
22 |
$1K |
| 0054A |
|
27 |
25 |
$1K |
| 93567 |
|
13 |
12 |
$998.24 |
| 84402 |
|
33 |
30 |
$963.06 |
| 94726 |
|
31 |
26 |
$948.19 |
| 76376 |
|
14 |
14 |
$940.66 |
| 92002 |
|
14 |
14 |
$925.56 |
| 76942 |
|
32 |
29 |
$867.62 |
| 86800 |
|
47 |
40 |
$864.10 |
| 90707 |
|
2,534 |
2,434 |
$850.70 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
31 |
16 |
$816.17 |
| 96116 |
|
15 |
14 |
$814.66 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
58 |
37 |
$809.10 |
| 90381 |
|
192 |
175 |
$795.87 |
| 86015 |
|
366 |
357 |
$766.23 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
13 |
13 |
$762.24 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
13 |
13 |
$758.20 |
| 90633 |
|
2,842 |
2,763 |
$733.97 |
| 81321 |
|
15 |
12 |
$720.00 |
| 86480 |
|
13 |
13 |
$713.85 |
| 90474 |
|
579 |
567 |
$671.61 |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
14 |
13 |
$667.92 |
| 81302 |
|
15 |
12 |
$633.44 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
8,337 |
7,846 |
$600.20 |
| 73080 |
|
29 |
27 |
$582.22 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
26 |
15 |
$575.85 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
15 |
14 |
$573.50 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,330 |
4,189 |
$572.76 |
| 87040 |
|
32 |
27 |
$560.79 |
| 0082A |
|
14 |
14 |
$560.00 |
| 87147 |
|
86 |
84 |
$557.32 |
| 75565 |
|
15 |
14 |
$527.80 |
| 84270 |
|
33 |
30 |
$523.85 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,473 |
6,283 |
$501.78 |
| 0004A |
|
13 |
12 |
$480.80 |
| 0154A |
|
12 |
12 |
$480.00 |
| 90651 |
|
1,037 |
1,015 |
$479.40 |
| 62367 |
|
18 |
13 |
$462.91 |
| 86709 |
|
176 |
169 |
$446.40 |
| 84550 |
|
181 |
150 |
$444.55 |
| 40806 |
|
81 |
72 |
$438.15 |
| 81243 |
|
21 |
12 |
$416.00 |
| 87015 |
|
119 |
86 |
$388.70 |
| 86696 |
|
291 |
281 |
$379.20 |
| 82746 |
|
42 |
39 |
$376.70 |
| 96381 |
|
87 |
68 |
$373.50 |
| 73562 |
|
36 |
36 |
$363.94 |
| 90734 |
|
372 |
355 |
$363.83 |
| 94664 |
|
27 |
26 |
$358.18 |
| 86160 |
|
110 |
103 |
$353.73 |
| 86708 |
|
189 |
183 |
$353.08 |
| 83001 |
|
15 |
12 |
$319.63 |
| 85055 |
|
12 |
12 |
$318.69 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
829 |
812 |
$318.01 |
| 51798 |
|
84 |
74 |
$309.83 |
| 70355 |
|
15 |
12 |
$304.78 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
21 |
20 |
$302.60 |
| 90674 |
|
4,330 |
4,273 |
$292.17 |
| 84590 |
|
25 |
24 |
$280.96 |
| J9370 |
Vincristine sulfate, 1 mg |
34 |
24 |
$276.21 |
| 85384 |
|
45 |
38 |
$271.23 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
52 |
22 |
$269.23 |
| 86695 |
|
291 |
281 |
$259.11 |
| 82435 |
|
133 |
103 |
$252.51 |
| 82627 |
|
12 |
12 |
$235.85 |
| 96130 |
|
96 |
96 |
$227.34 |
| 92134 |
|
18 |
16 |
$217.79 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
12 |
12 |
$209.70 |
| 84446 |
|
14 |
13 |
$206.27 |
| 99381 |
|
76 |
71 |
$206.00 |
| 69210 |
|
41 |
39 |
$196.03 |
| 95885 |
|
31 |
25 |
$196.02 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
132 |
88 |
$191.90 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
168 |
150 |
$184.38 |
| J1756 |
Injection, iron sucrose, 1 mg |
25 |
12 |
$180.44 |
| 82077 |
|
13 |
13 |
$177.78 |
| 87807 |
|
12 |
12 |
$176.30 |
| G0381 |
Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
12 |
12 |
$169.30 |
| 85014 |
|
41 |
39 |
$140.74 |
| 87210 |
|
47 |
41 |
$125.84 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
63 |
36 |
$120.84 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
15 |
15 |
$104.42 |
| 82274 |
|
14 |
14 |
$99.96 |
| 82525 |
|
17 |
17 |
$89.98 |
| V5266 |
Battery for use in hearing device |
17 |
13 |
$84.60 |
| 85049 |
|
15 |
14 |
$77.20 |
| 90700 |
|
150 |
147 |
$73.27 |
| 92015 |
Determination of refractive state |
142 |
137 |
$72.80 |
| 87088 |
|
15 |
13 |
$72.10 |
| 83525 |
|
14 |
12 |
$69.17 |
| 85245 |
|
17 |
13 |
$65.22 |
| 85246 |
|
17 |
13 |
$65.22 |
| 83010 |
|
70 |
69 |
$63.90 |
| 92250 |
|
14 |
14 |
$63.63 |
| 89051 |
|
13 |
12 |
$59.74 |
| 85240 |
|
17 |
13 |
$50.90 |
| 82787 |
|
46 |
43 |
$22.44 |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
12 |
12 |
$17.60 |
| 80354 |
|
818 |
617 |
$12.08 |
| 80047 |
|
31 |
30 |
$11.91 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,408 |
1,304 |
$10.42 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
69 |
25 |
$9.96 |
| 91300 |
|
591 |
462 |
$4.69 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
61 |
38 |
$2.82 |
| 91307 |
|
286 |
281 |
$2.33 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
30 |
25 |
$0.04 |
| 90680 |
|
5,890 |
5,503 |
$0.00 |
| 88300 |
|
381 |
369 |
$0.00 |
| A9270 |
Non-covered item or service |
528 |
315 |
$0.00 |
| 87116 |
|
103 |
74 |
$0.00 |
| 96131 |
|
80 |
79 |
$0.00 |
| 90696 |
|
110 |
106 |
$0.00 |
| 96139 |
|
64 |
63 |
$0.00 |
| 87206 |
|
103 |
74 |
$0.00 |
| 88307 |
|
13 |
12 |
$0.00 |
| 92650 |
|
13 |
12 |
$0.00 |
| 83498 |
|
14 |
13 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
15 |
14 |
$0.00 |
| J3430 |
Injection, phytonadione (vitamin k), per 1 mg |
13 |
12 |
$0.00 |
| 83789 |
|
14 |
13 |
$0.00 |
| 80348 |
|
4,477 |
3,422 |
$0.00 |
| 92025 |
|
26 |
24 |
$0.00 |
| A0100 |
Non-emergency transportation; taxi |
106 |
102 |
$0.00 |
| 76000 |
|
14 |
13 |
$0.00 |
| 81479 |
Unlisted molecular pathology procedure |
14 |
13 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
131 |
127 |
$0.00 |
| 96137 |
|
95 |
94 |
$0.00 |
| 82760 |
|
14 |
13 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
250 |
246 |
$0.00 |
| 80175 |
|
25 |
24 |
$0.00 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
12 |
12 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
25 |
15 |
$0.00 |